<p>据 Marketbeat.com 报道，覆盖该股票的七家经纪公司给 Cresco Labs Inc. (OTCMKTS:CRLBF - 获取免费报告) 的股票普遍推荐为&#34;买入&#34;。两位投资分析师给予该股票持有评级，三位给予买入评级，两位给予强烈买入评级。过去一年内覆盖该股票的分析师中，平均 1 年目标价为 16.00 美元。</p>
<ul>
<li>Cresco Labs 领先美国大麻市场</li>
</ul>
<p>CRLBF 最近成为多份研究报告的主题。Wedbush 将 Cresco Labs 的目标股价从 2.50 美元上调至 3.00 美元，并在 5 月 16 日星期四的研究报告中给予该股票&#34;表现优异&#34;评级。Ventum Cap Mkts 在周五的研究报告中将 Cresco Labs 评级提升至&#34;强烈买入&#34;。Needham &amp; Company LLC 在 5 月 16 日星期四的报告中重申了对 Cresco Labs 的&#34;持有&#34;评级。最后，Roth Capital 在周五的报告中将 Cresco Labs 的评级从&#34;持有&#34;上调至&#34;强烈买入&#34;。</p>
<p><strong>阅读我们关于 CRLBF 的最新股票分析</strong></p>
<h2>Cresco Labs 股价下跌 4.0%</h2>
<ul>
<li>押注美国大麻的另外两个理由</li>
</ul>
<p>CRLBF 周五开盘价为 1.56 美元。公司的资产负债比为 1.57，速动比率为 0.89，流动比率为 1.36。 Cresco Labs 的 52 周最低价为 1.00 美元，52 周最高价为 2.77 美元。公司的 50 天移动平均价格为 1.65 美元，200 天移动平均价格为 1.89 美元。该公司的市值为 7.615 亿美元，市盈率为-3.32，β系数为 1.86。</p>
<p>Cresco Labs (OTCMKTS:CRLBF - 获取免费报告) 上次公布季度财报是在 8 月 8 日星期四。公司报告该季度每股收益为（0.16）美元，低于（0.01）美元的共识预期（差额为 0.15 美元）。 Cresco Labs 的净资产收益率为-6.78%，净利润率为-20.32%。该季度公司的营收为 1.8436 亿美元，略高于分析师预期的 1.8426 亿美元。股票分析师预计，Cresco Labs 在本财年将发布-0.03 美元的每股收益。</p>
<h2>关于 Cresco Labs（获取免费报告）</h2>
<ul>
<li>Cresco Labs OTCMKTS: CRLBF 在第三季度加速盈利</li>
</ul>
<p>Cresco Labs Inc.及其子公司在美国种植、生产和销售零售和医用大麻产品。公司提供 Cresco 品牌的大麻花、雾化笔、活性树脂、一次性笔和提取物；High Supply 品牌的雾化笔、雾化笔、花朵、爆米花、摇晃、预卷、短款和浓缩物；Good News 品牌的雾化笔和软糖；Wonder Wellness Co 品牌的雾化笔和食用品；Remedi 品牌的滴剂、胶囊、药膏和舌下油。</p>
<h2>精选文章</h2>
<ul>
<li>我们喜欢的五只股票</li>
<li>投资者必须了解的场外（OTC）股票</li>
<li>Cassava Sciences：一个热门股票，可以交易、投资或避免？</li>
<li>如何投资最佳的加拿大股票</li>
<li>MarketBeat 周评 - 8/5 - 8/9</li>
<li>投资石油股的方法和原因</li>
<li>大麻行业：盈利能力成为焦点</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG"/></p>
<p><em>此即时新闻警报由 MarketBeat 的叙事科技和金融数据生成，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<p>→ 美国正在研发 “结束战争的超级武器”？（来自 Paradigm Press）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTMw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTMw"/></p>
<h2>您现在是否应该投资 1000 美元购买 Cresco Labs 股票？</h2>
<p>在考虑 Cresco Labs 之前，您可能想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶尖和表现最佳的研究分析师以及他们建议客户购买的股票。MarketBeat 已确定了五只顶尖分析师悄悄告诉客户在更广泛市场注意之前现在购买的股票... Cresco Labs 不在名单上。</p>
<p>尽管 Cresco Labs 目前在分析师中有&#34;中等买入&#34;评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

CRLBF

<p>Cresco Labs Inc.收到分析师一致的 “买入” 推荐。该股票有两个持有评级，三个买入评级和两个强烈买入评级。平均目标价格为 16.00 美元。Cresco Labs 是美国大麻市场的领先公司。该公司报告了本季度的每股收益为负值和负净利润率。该公司的股价开盘价为 1.56 美元</p>

<p>Shares of Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) have received a consensus recommendation of &#34;Buy&#34; from the seven brokerages that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and two have assigned a strong buy rating to the company. The average 1 year target price among analysts that have covered the stock in the last year is $16.00.</p>
<ul>
<li>Cresco Labs Is Leading The U.S. Cannabis Market</li>
</ul>
<div class="lb-trans"><p>据 Marketbeat.com 报道，覆盖该股票的七家经纪公司给 Cresco Labs Inc. (OTCMKTS:CRLBF - 获取免费报告) 的股票普遍推荐为&#34;买入&#34;。两位投资分析师给予该股票持有评级，三位给予买入评级，两位给予强烈买入评级。过去一年内覆盖该股票的分析师中，平均 1 年目标价为 16.00 美元。</p>
<ul>
<li>Cresco Labs 领先美国大麻市场</li>
</ul>
</div><p>CRLBF has been the topic of several recent research reports. Wedbush increased their price objective on shares of Cresco Labs from $2.50 to $3.00 and gave the stock an &#34;outperform&#34; rating in a research note on Thursday, May 16th. Ventum Cap Mkts raised Cresco Labs to a &#34;strong-buy&#34; rating in a research note on Friday. Needham &amp; Company LLC reaffirmed a &#34;hold&#34; rating on shares of Cresco Labs in a report on Thursday, May 16th. Finally, Roth Capital upgraded Cresco Labs from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Friday.</p>
<div class="lb-trans"><p>CRLBF 最近成为多份研究报告的主题。Wedbush 将 Cresco Labs 的目标股价从 2.50 美元上调至 3.00 美元，并在 5 月 16 日星期四的研究报告中给予该股票&#34;表现优异&#34;评级。Ventum Cap Mkts 在周五的研究报告中将 Cresco Labs 评级提升至&#34;强烈买入&#34;。Needham &amp; Company LLC 在 5 月 16 日星期四的报告中重申了对 Cresco Labs 的&#34;持有&#34;评级。最后，Roth Capital 在周五的报告中将 Cresco Labs 的评级从&#34;持有&#34;上调至&#34;强烈买入&#34;。</p>
</div><p><strong>Read Our Latest Stock Analysis on CRLBF</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 CRLBF 的最新股票分析</strong></p>
</div><h2>Cresco Labs Trading Down 4.0 %</h2>
<ul>
<li>Two More Reasons To Bet Big On U.S. Cannabis</li>
</ul>
<div class="lb-trans"><h2>Cresco Labs 股价下跌 4.0%</h2>
<ul>
<li>押注美国大麻的另外两个理由</li>
</ul>
</div><p>Shares of CRLBF opened at $1.56 on Friday. The company has a debt-to-equity ratio of 1.57, a quick ratio of 0.89 and a current ratio of 1.36. Cresco Labs has a 52-week low of $1.00 and a 52-week high of $2.77. The business's fifty day moving average is $1.65 and its 200-day moving average is $1.89. The firm has a market cap of $761.50 million, a price-to-earnings ratio of -3.32 and a beta of 1.86.</p>
<div class="lb-trans"><p>CRLBF 周五开盘价为 1.56 美元。公司的资产负债比为 1.57，速动比率为 0.89，流动比率为 1.36。 Cresco Labs 的 52 周最低价为 1.00 美元，52 周最高价为 2.77 美元。公司的 50 天移动平均价格为 1.65 美元，200 天移动平均价格为 1.89 美元。该公司的市值为 7.615 亿美元，市盈率为-3.32，β系数为 1.86。</p>
</div><p>Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.15). Cresco Labs had a negative return on equity of 6.78% and a negative net margin of 20.32%. The company had revenue of $184.36 million for the quarter, compared to analysts' expectations of $184.26 million. Equities analysts anticipate that Cresco Labs will post -0.03 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Cresco Labs (OTCMKTS:CRLBF - 获取免费报告) 上次公布季度财报是在 8 月 8 日星期四。公司报告该季度每股收益为（0.16）美元，低于（0.01）美元的共识预期（差额为 0.15 美元）。 Cresco Labs 的净资产收益率为-6.78%，净利润率为-20.32%。该季度公司的营收为 1.8436 亿美元，略高于分析师预期的 1.8426 亿美元。股票分析师预计，Cresco Labs 在本财年将发布-0.03 美元的每股收益。</p>
</div><h2>About Cresco Labs (Get Free Report</h2>
<ul>
<li>Cresco Labs OTCMKTS: CRLBF Accelerates To Profits In Q3</li>
</ul>
<div class="lb-trans"><h2>关于 Cresco Labs（获取免费报告）</h2>
<ul>
<li>Cresco Labs OTCMKTS: CRLBF 在第三季度加速盈利</li>
</ul>
</div><p>Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.</p>
<div class="lb-trans"><p>Cresco Labs Inc.及其子公司在美国种植、生产和销售零售和医用大麻产品。公司提供 Cresco 品牌的大麻花、雾化笔、活性树脂、一次性笔和提取物；High Supply 品牌的雾化笔、雾化笔、花朵、爆米花、摇晃、预卷、短款和浓缩物；Good News 品牌的雾化笔和软糖；Wonder Wellness Co 品牌的雾化笔和食用品；Remedi 品牌的滴剂、胶囊、药膏和舌下油。</p>
</div><h2>Featured Articles</h2>
<ul>
<li>Five stocks we like better than Cresco Labs</li>
<li>What Investors Must Know About Over-the-Counter (OTC) Stocks</li>
<li>Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?</li>
<li>How to Invest in the Best Canadian Stocks</li>
<li>MarketBeat Week in Review – 8/5 - 8/9</li>
<li>The How And Why of Investing in Oil Stocks</li>
<li>The Cannabis Sector: Profitability Takes Center Stage</li>
</ul>
<div class="lb-trans"><h2>精选文章</h2>
<ul>
<li>我们喜欢的五只股票</li>
<li>投资者必须了解的场外（OTC）股票</li>
<li>Cassava Sciences：一个热门股票，可以交易、投资或避免？</li>
<li>如何投资最佳的加拿大股票</li>
<li>MarketBeat 周评 - 8/5 - 8/9</li>
<li>投资石油股的方法和原因</li>
<li>大麻行业：盈利能力成为焦点</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU9UQ01LVFMmU3ltYm9sPUNSTEJG" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=OTCMKTS&amp;Symbol=CRLBF"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由 MarketBeat 的叙事科技和金融数据生成，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><p>→ US developing “war ending superweapon”? (From Paradigm Press)(Ad)</p>
<div class="lb-trans"><p>→ 美国正在研发 “结束战争的超级武器”？（来自 Paradigm Press）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05MTMw" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9130&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Cresco Labs right now?</h2>
<div class="lb-trans"><h2>您现在是否应该投资 1000 美元购买 Cresco Labs 股票？</h2>
</div><p>Before you consider Cresco Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Cresco Labs 之前，您可能想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶尖和表现最佳的研究分析师以及他们建议客户购买的股票。MarketBeat 已确定了五只顶尖分析师悄悄告诉客户在更广泛市场注意之前现在购买的股票... Cresco Labs 不在名单上。</p>
</div><p>While Cresco Labs currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Cresco Labs 目前在分析师中有&#34;中等买入&#34;评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Cresco Labs Inc. (OTCMKTS:CRLBF) 获得分析师一致推荐的 “买入” 评级